Immediate Impact
1 by Nobel laureates 8 from Science/Nature 76 standout
Citing Papers
Fibrosis in IBD: from pathogenesis to therapeutic targets
2024 Standout
Strategies for targeting cytokines in inflammatory bowel disease
2024 Standout
Works of Peter Uebel being referenced
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
2014
OP011 Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe ulcerative colitis: A phase 2 randomized placebo-controlled study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Peter Uebel | 141 | 69 | 41 | 83 | 79 | 8 | 254 | |
| E. Fréling | 211 | 156 | 54 | 66 | 85 | 7 | 320 | |
| Julie Galsgaard | 135 | 82 | 11 | 121 | 50 | 6 | 281 | |
| Shaista Rashid | 152 | 92 | 13 | 145 | 56 | 10 | 325 | |
| Purushothaman Premchand | 194 | 161 | 39 | 42 | 97 | 11 | 310 | |
| Silvia Bakos | 144 | 90 | 30 | 92 | 63 | 8 | 334 | |
| Josh Korzenik | 174 | 111 | 18 | 60 | 78 | 7 | 317 | |
| Kriszta Molnár | 71 | 68 | 76 | 53 | 109 | 15 | 274 | |
| Maja Ideström | 185 | 121 | 12 | 101 | 82 | 8 | 297 | |
| David I. Weinberg | 151 | 86 | 30 | 34 | 72 | 6 | 276 | |
| Kazuhiko Sugawara | 93 | 49 | 36 | 113 | 65 | 9 | 326 |
All Works
Loading papers...